Expanding Capabilities in the Biologics Sector Piramal Pharma Limited (PPL) has officially announced the successful completion of its acquisition of a majority stake in Yapan Bio Private Limited. This strategic move marks a significant milestone in Piramal’s ongoing effort to broaden its service offerings within the rapidly evolving biologics and advanced therapy medicinal products (ATMPs)…